IN
INCY
HealthcareIncyte Corporation
Biotechnology
Total Trades
8
Unique Traders
2
Purchases / Sales
4/4
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Mar 30, 2026 |  Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $90.33 | $99.10 | +9.7% | -2.9% | |
Mar 10, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $96.02 | $96.96 | +1.0% | +0.3% | |
Jan 29, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $101.08 | $101.27 | +0.2% | +1.3% | |
May 19, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $63.81 | $68.27 | +7.0% | +6.6% | |
May 15, 2025 |  Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $62.76 | $67.75 | +8.0% | +6.8% | |
Feb 19, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $70.16 | $61.92 | -11.7% | -4.0% | |
Jan 17, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $71.93 | $70.42 | -2.1% | -4.1% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $67.55 | $71.93 | +6.5% | +4.2% |
Recent News
Incyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology Collaboration - Has The Bull Case Changed?
Yahoo-Invalid Date
Incyte Corp. stock outperforms competitors on strong trading day
MarketWatch-Invalid Date
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Yahoo-Invalid Date
Adagene Collaborates With Incyte To Evaluate Combination Of Muzastotug And INCA33890 In Patients With Microsatellite Stable Colorectal Cancer With Or Without Liver Metastases
Benzinga-Invalid Date
5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up
Yahoo-Invalid Date